{"id":2532,"date":"2017-07-07T09:34:54","date_gmt":"2017-07-07T13:34:54","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2532"},"modified":"2017-07-09T07:22:38","modified_gmt":"2017-07-09T11:22:38","slug":"ipo-pipeline-update-new-filings-updated-terms-week-ending-7-7-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-new-filings-updated-terms-week-ending-7-7-17\/","title":{"rendered":"IPO Pipeline Update: New Filings &#038; Updated Terms (Week ending 7.7.17)"},"content":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of July 7, 2017. No SPACs or Unit Offerings are included.<br \/>\n<a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-2533\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart.png\" alt=\"chart\" width=\"746\" height=\"461\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart.png 746w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-600x371.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/07\/chart-300x185.png 300w\" sizes=\"(max-width: 746px) 100vw, 746px\" \/><\/a><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>Company: <strong>Sienna Biopharmaceuticals, Inc.<\/strong><br \/>\nSymbol: SNNA<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of first-in-class, targeted, topical products in medical dermatology and aesthetics<br \/>\nTrade Date: TBD<br \/>\nPrice: TBD<br \/>\nShares: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Cowen, BMO Capital Markets<br \/>\nTerms Added: 7-3-17<\/p>\n<p>Company: <strong>Tremont Mortgage Trust<\/strong><br \/>\nSymbol: TRMT<br \/>\nDescription: They are a real estate finance company that plans to focus primarily on originating and investing in first mortgage loans secured by middle market and transitional commercial real estate, or CRE.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): UBS Investment Bank, Citigroup, RBC Capital Markets<br \/>\nFiled: 7-7-17<br \/>\nListed Cash Raise: $100 million<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 57 active IPOs in the pipeline as of July 7, 2017. No SPACs or Unit Offerings are included. NEW FILINGS Company: Sienna Biopharmaceuticals, Inc. Symbol: SNNA Description: They are a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[1276],"class_list":["post-2532","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-snna"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2532"}],"version-history":[{"count":4,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2532\/revisions"}],"predecessor-version":[{"id":2553,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2532\/revisions\/2553"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}